Skip to content
10-K

Annual Report

Moderna, Inc. MRNA

0001682852-26-000033

← back to feed
Filed
Feb 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 394.94M sh
Shares Diluted FY 2025 · Dec 31, 2025 389M sh
Shares Diluted FY 2025 · Dec 31, 2024 384M sh
Shares Diluted FY 2025 · Dec 31, 2023 382M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $2M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $1.15B
Capex FY 2025 · Dec 31, 2025 $192M
Capex FY 2025 · Dec 31, 2024 $1.05B
Capex FY 2025 · Dec 31, 2023 $707M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.87B
Operating Cash Flow FY 2025 · Dec 31, 2024 −$3B
Operating Cash Flow FY 2025 · Dec 31, 2023 −$3.12B
Long Term Debt FY 2025 · Dec 31, 2025 $590M
Long Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.6B
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.93B
Cash And Equivalents FY 2025 · Dec 31, 2023 $2.91B
Stockholders Equity FY 2025 · Dec 31, 2025 $8.65B
Stockholders Equity FY 2025 · Dec 31, 2024 $10.9B
Stockholders Equity FY 2025 · Dec 31, 2023 $13.85B
Stockholders Equity FY 2025 · Dec 31, 2022 $19.12B
Current Liabilities FY 2025 · Dec 31, 2025 $1.99B
Current Liabilities FY 2025 · Dec 31, 2024 $2.21B
Total Liabilities FY 2025 · Dec 31, 2025 $3.69B
Total Liabilities FY 2025 · Dec 31, 2024 $3.24B
Current Assets FY 2025 · Dec 31, 2025 $6.54B
Current Assets FY 2025 · Dec 31, 2024 $8.1B
Total Assets FY 2025 · Dec 31, 2025 $12.34B
Total Assets FY 2025 · Dec 31, 2024 $14.14B
Eps Diluted FY 2025 · Dec 31, 2025 −$7.26
Eps Diluted FY 2025 · Dec 31, 2024 −$9.28
Eps Diluted FY 2025 · Dec 31, 2023 −$12.33
Eps Basic FY 2025 · Dec 31, 2025 −$7.26
Eps Basic FY 2025 · Dec 31, 2024 −$9.28
Eps Basic FY 2025 · Dec 31, 2023 −$12.33
Sga Expense FY 2025 · Dec 31, 2025 $1.02B
Sga Expense FY 2025 · Dec 31, 2024 $1.17B
Sga Expense FY 2025 · Dec 31, 2023 $1.55B
Rd Expense FY 2025 · Dec 31, 2025 $3.13B
Rd Expense FY 2025 · Dec 31, 2024 $4.54B
Rd Expense FY 2025 · Dec 31, 2023 $4.85B
Net Income FY 2025 · Dec 31, 2025 −$2.82B
Net Income FY 2025 · Dec 31, 2024 −$3.56B
Net Income FY 2025 · Dec 31, 2023 −$4.71B
Operating Income FY 2025 · Dec 31, 2025 −$3.07B
Operating Income FY 2025 · Dec 31, 2024 −$3.95B
Operating Income FY 2025 · Dec 31, 2023 −$4.24B
Cost Of Revenue FY 2025 · Dec 31, 2025 $868M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.46B
Cost Of Revenue FY 2025 · Dec 31, 2023 $4.69B
Revenue FY 2025 · Dec 31, 2025 $1.94B
Revenue FY 2025 · Dec 31, 2024 $3.24B
Revenue FY 2025 · Dec 31, 2023 $6.85B